Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma
Open Access
- 7 June 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (2) , 1581-1587
Abstract
Poly (ADP-ribose) polymerase-1 (PARP1) plays a vital role in DNA repair and is expected to be an effective target in various malignancies. The aim of the present study was to investigate the clinical and biological significance of PARP1 expression in esophageal squamous cell carcinoma (ESCC). Immunohistochemical (IHC) staining was used to examine the association between PARP1 expression and the clinicopathological features of 86 patients with ESCC. The antitumor effect of small interfering RNA against PARP1 (siPARP1) was examined in a proliferation assay, and the mechanisms of this effect were investigated using western blot analysis and cell cycle assays. Cox multivariate analysis revealed that high expression of PARP1 in IHC staining was a statistically significant independent prognostic factor of poor overall survival (OS). The adjusted hazard ratio for OS in the group with high expression of PARP1 was 2.39 (95% confidence interval, 1.29–4.44; P=0.0051). In vitro assays showed that siPARP1 significantly decreased proliferation through G2/M arrest. Furthermore, western blot analysis showed that PARP1 was associated with the ataxia telangiectasia mutated-checkpoint kinase 2-cell division control 25c pathway. The present study suggests that PARP1 expression has a critical role in ESCC progression, and may be a clinical therapeutic target.Keywords
This publication has 21 references indexed in Scilit:
- TNM seventh edition: What's new, what's changedCancer, 2010
- PARP inhibition: PARP1 and beyondNature Reviews Cancer, 2010
- DNA Damage, Aging, and CancerNew England Journal of Medicine, 2009
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsProceedings of the National Academy of Sciences, 2008
- Oesophagectomy after Definitive Chemoradiation in Patients with Locally Advanced Oesophageal CancerClinical Oncology, 2008
- DNA repair pathways as targets for cancer therapyNature Reviews Cancer, 2008
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- (ADP-ribose)n participates in DNA excision repairNature, 1980
- Poly(ADP-ribose) levels in carcinogen-treated cellsNature, 1979